Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07420283
PHASE2

A Study of Brenipatide in Participants With Opioid Use Disorder

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A is approximately 144 weeks, maximum potential duration of study participation for a participant in Part B is approximately 116 weeks. The actual duration will vary for each participant depending on the time of enrollment and the overall rate of study enrollment.

Official title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study With a Separate Open-label Cohort to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Transmucosal Buprenorphine With or Without Naloxone in Early Recovery of Participants With Opioid Use Disorder (RENEW-Op-1)

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

465

Start Date

2026-02-13

Completion Date

2028-02

Last Updated

2026-03-04

Healthy Volunteers

No

Interventions

DRUG

Brenipatide

Administered SC

DRUG

Placebo

Administered SC

DRUG

Buprenorphine

Administered sublingual or buccal

Locations (56)

Parkway Medical Center

Birmingham, Alabama, United States

NoesisPharma - Phoenix - East Shea Boulevard

Phoenix, Arizona, United States

Woodland International Research Group

Little Rock, Arkansas, United States

Ark Clinical Research - Fountain Valley

Fountain Valley, California, United States

Center on Substance Use and Health (CSUH)

San Francisco, California, United States

UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay

San Francisco, California, United States

Bradenton Research Center, Inc.

Bradenton, Florida, United States

K2 Medical Research - Daytona Beach

Daytona Beach, Florida, United States

NextPhase Research Florida - Hollywood

Hollywood, Florida, United States

Accel Research Sites - Lakeland Clinical Research Unit

Lakeland, Florida, United States

Life Arc Research Centers - Miami

Miami, Florida, United States

Advanced Research for Health Improvement, LLC

Naples, Florida, United States

Innovative Research Institute - Port Charlotte

Port Charlotte, Florida, United States

Better Years Ahead Medical Center

Tampa, Florida, United States

Neuroscience Research Institute - West Palm Beach

West Palm Beach, Florida, United States

Re:Cognition Health - Chicago

Chicago, Illinois, United States

Indiana University Health Neuroscience Center

Indianapolis, Indiana, United States

University of Kentucky Chandler Medical Center

Lexington, Kentucky, United States

Maryland Treatment Centers - Mountain Manor Treatment Center

Baltimore, Maryland, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

Adams Clinical Boston

Boston, Massachusetts, United States

Boston Medical Center

Boston, Massachusetts, United States

Adams Clinical Watertown

Watertown, Massachusetts, United States

SKY Integrative Medical Center/SKYCRNG

Ridgeland, Mississippi, United States

Adams Clinical Harlem

New York, New York, United States

Adams Clinical Bronx

The Bronx, New York, United States

Ohio Clinical Trials

Columbus, Ohio, United States

Rivus Wellness and Research Institute

Oklahoma City, Oklahoma, United States

Adams Clinical Philadelphia

Philadelphia, Pennsylvania, United States

Penn Medicine: University of Pennsylvania Health System

Philadelphia, Pennsylvania, United States

Brown University School of Public Health

Providence, Rhode Island, United States

Avera Research Institute - Sioux Falls

Sioux Falls, South Dakota, United States

Adams Clinical Dallas

DeSoto, Texas, United States

Biopharma Informatic, LLC

Houston, Texas, United States

University of Virginia Health System

Charlottesville, Virginia, United States

Carilion Clinic

Roanoke, Virginia, United States

University of Washington - Harborview Medical Center

Seattle, Washington, United States

CaRe Clinic

Calgary, Canada

Med Trust Research

Courtice, Canada

Kelowna Health and Memory Centre

Kelowna, Canada

Providence Care

Kingston, Canada

Malton Medical Group

Mississauga, Canada

Comprehensive Treatment Clinic

Toronto, Canada

Centre for Addiction and Mental Health (CAMH)

Toronto, Canada

Gordon and Leslie Diamond Health Care Centre

Vancouver, Canada

Research Works San Juan

Guaynabo, Puerto Rico

Surrey and Borders Partnership NHS Foundation Trust

Chertsey, United Kingdom

Queen Elizabeth University Hospital

Glasgow, United Kingdom

St Pancras Clinical Research

London, United Kingdom

Bioluminux - London

London, United Kingdom

Lambeth Drug and Alcohol Treatment Consortium

London, United Kingdom

Bioluminux Clinical Research - Milton Keynes

Milton Keynes, United Kingdom

Salford Royal Hospital

Salford, United Kingdom

Bioluminux - Southampton

Southampton, United Kingdom

Old Bank House Hillingdon Drug & Alcohol

Uxbridge, United Kingdom

Bioluminux - Wolverhampton

Wolverhampton, United Kingdom